| On Wednesday, the Food and Drug Administration | | | | This comes to good news to those suffering from |
| approved extended release Invega for the treatment | | | | schizophrenia. The National Institute of Mental Health |
| of schizophrenia. | | | | states, "Schizophrenia is a chronic, severe, and |
| The approval was based on the results of 3, 6 week | | | | disabling brain disorder that affects about 1 percent |
| studies which were conducted in North America, | | | | of people all over the world. People with |
| Europe, Asia, and involved 1,665 participants. These | | | | schizophrenia sometimes hear voices others don't |
| studies concluded that Invega was more effective | | | | hear, believe that others are broadcasting their |
| than a placebo for relieving symptoms associated | | | | thoughts to the world, or become convinced that |
| with schizophrenia. | | | | others are plotting to harm them. These experiences |
| The patients in the group were given doses | | | | can make them fearful and withdrawn and cause |
| medication from 3 milligrams to 15 milligrams a day. | | | | difficulties when they try to have relationships with |
| Although minor, some of the side affects | | | | others." |
| experienced by patients included restlessness, | | | | According to Healthday, the FDA concluded that |
| movement disorders, rapid heart beat, and sleepiness. | | | | since the medication has not been tested for a |
| Also, Invega belongs to the class of drugs called | | | | period over 6 weeks, patients taking the medication |
| atypical antipsychotic which have been linked to an | | | | long term should schedule regular visits to be |
| increased rate of death among elderly patients with | | | | monitored by a licensed physician. |
| dementia related psychosis. Thankfully this relates to | | | | Visit this Consumer Advocacy website for more |
| a very small percentage of users. | | | | information on ordering from online no prescription. |